FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 54 filers reported holding FORTRESS BIOTECH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $261,461 | -44.7% | 900,400 | +4.8% | 0.00% | – |
Q2 2023 | $472,661 | -17.5% | 859,385 | +23.1% | 0.00% | – |
Q1 2023 | $572,595 | +128862.8% | 698,287 | +3.0% | 0.00% | – |
Q4 2022 | $444 | -99.9% | 678,222 | -0.2% | 0.00% | – |
Q3 2022 | $584,000 | +2.6% | 679,748 | +0.3% | 0.00% | – |
Q2 2022 | $569,000 | -67.1% | 677,518 | -46.7% | 0.00% | – |
Q1 2022 | $1,730,000 | -48.6% | 1,272,119 | -5.6% | 0.00% | – |
Q4 2021 | $3,369,000 | -23.1% | 1,347,602 | -1.0% | 0.00% | -100.0% |
Q3 2021 | $4,382,000 | -6.6% | 1,361,169 | +3.6% | 0.00% | 0.0% |
Q2 2021 | $4,690,000 | +13.5% | 1,313,787 | +12.2% | 0.00% | 0.0% |
Q1 2021 | $4,131,000 | +39.7% | 1,170,459 | +25.5% | 0.00% | – |
Q4 2020 | $2,956,000 | -17.5% | 932,712 | +5.2% | 0.00% | -100.0% |
Q3 2020 | $3,582,000 | +77.4% | 886,906 | +17.6% | 0.00% | – |
Q2 2020 | $2,019,000 | +208.7% | 753,976 | +117.8% | 0.00% | – |
Q1 2020 | $654,000 | -63.6% | 346,163 | -50.5% | 0.00% | – |
Q4 2019 | $1,796,000 | +262.1% | 698,996 | +98.3% | 0.00% | – |
Q3 2019 | $496,000 | -7.1% | 352,463 | -1.0% | 0.00% | – |
Q2 2019 | $534,000 | -39.7% | 356,140 | -28.4% | 0.00% | – |
Q1 2019 | $885,000 | +35.7% | 497,635 | -34.5% | 0.00% | – |
Q4 2018 | $652,000 | +21.2% | 759,944 | +125.7% | 0.00% | – |
Q3 2018 | $538,000 | -44.1% | 336,733 | +4.2% | 0.00% | – |
Q2 2018 | $963,000 | -30.0% | 323,288 | +7.0% | 0.00% | – |
Q1 2018 | $1,375,000 | +15.8% | 302,211 | +1.5% | 0.00% | – |
Q4 2017 | $1,187,000 | -8.8% | 297,713 | +1.0% | 0.00% | – |
Q3 2017 | $1,302,000 | -6.7% | 294,663 | +0.2% | 0.00% | -100.0% |
Q2 2017 | $1,396,000 | +30.8% | 293,964 | +1.9% | 0.00% | – |
Q1 2017 | $1,067,000 | +41.5% | 288,566 | +3.2% | 0.00% | – |
Q4 2016 | $754,000 | -6.6% | 279,608 | +2.9% | 0.00% | – |
Q3 2016 | $807,000 | +14.0% | 271,799 | +3.1% | 0.00% | – |
Q2 2016 | $708,000 | -0.7% | 263,560 | +14.5% | 0.00% | – |
Q1 2016 | $713,000 | +10.9% | 230,279 | -0.1% | 0.00% | – |
Q4 2015 | $643,000 | +12.2% | 230,495 | +4.5% | 0.00% | – |
Q3 2015 | $573,000 | – | 220,620 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Belmont Global Advisors, Inc. | 550,000 | $1,479,000 | 1.42% |
Avoro Capital Advisors LLC | 1,326,636 | $3,569,000 | 0.79% |
Geduld E E | 10,000 | $27,000 | 0.04% |
ELLIOTT MANAGEMENT CORP | 1,074,707 | $2,891,000 | 0.02% |
HighPoint Advisor Group LLC | 14,230 | $42,000 | 0.02% |
Acrospire Investment Management LLC | 7,179 | $19,000 | 0.01% |
B. Riley Wealth Advisors, Inc. | 24,100 | $65,000 | 0.01% |
ClariVest Asset Management LLC | 117,719 | $316,000 | 0.01% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 15,985 | $43,000 | 0.01% |
DENVER INVESTMENT ADVISORS LLC | 26,908 | $72,000 | 0.00% |